45.77M Market Cap
Loss P/E TTM
Key Figures
-- Open
0.000 High
0.00 Volume
Loss P/E TTM
Loss P/E Dynamic
-- Dividend TTM
1.09% Turnover Ratio
1.740 Prev. Close
0.000 Low
0.00 Turnover
Loss P/E Static
3.61 P/B
0.00% Div Yield TTM
-34.41% ROA
2.000 52wk High
1.10 Volume Ratio
-25.11M Net Profit
26.31M Shares
-0.8652 EPS TTM
0.44 Beta
-101.92% ROE
0.850 52wk Low
11.05% Amplitude
100.00% Gross Margin
45.77M Market Cap
3.36 Reward/Risk
3.70% Risk Rate
TradingKey Stock Score No stock score available due to insufficient data.
LAVA Therapeutics NV News
View more
More news coming soon, stay tuned...
Financial Indicators EPS Relevant data have not been disclosed by the company yet.
Total revenue Relevant data have not been disclosed by the company yet.
LAVA Therapeutics NV Info LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Ticker Symbol LVTX
Company LAVA Therapeutics NV
CEO Mr. Stephen A. Hurly
Website https://www.lavatherapeutics.com/
FAQs
What is the current price of LAVA Therapeutics NV (LVTX)? The current price of LAVA Therapeutics NV (LVTX) is 1.74.
What is the symbol of LAVA Therapeutics NV? The ticker symbol of LAVA Therapeutics NV is LVTX.
What is the 52-week high of LAVA Therapeutics NV? The 52-week high of LAVA Therapeutics NV is 2.00.
What is the 52-week low of LAVA Therapeutics NV? The 52-week low of LAVA Therapeutics NV is 0.85.
What is the market capitalization of LAVA Therapeutics NV? The market capitalization of LAVA Therapeutics NV is 45.77M.
What is the Earnings Per Share (EPS TTM) of LAVA Therapeutics NV (LVTX)? The Earnings Per Share (EPS TTM) of LAVA Therapeutics NV (LVTX) is -0.94.